IMNM - Immunome, Inc.
NEXT EARNINGS:
Mar 18, 2026
(in 21 days)
EPS Est: $-0.65
|
Rev Est: $784620
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$35.29
DETAILS
HIGH:
$40.00
LOW:
$26.00
MEDIAN:
$36.00
CONSENSUS:
$35.29
UPSIDE:
59.54%
Market Cap:
2.03B
Volume:
551,829
Avg Volume:
2,080,900
52 Week Range:
5.15-27.65
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.11
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
131
IPO Date:
2020-10-02
EPS (TTM):
-5.00
P/E Ratio:
-2.13
Revenue (TTM):
9.04M
Total Assets:
240.24M
Total Debt:
4.83M
Cash & Equiv:
143.35M
Rev Growth (5Y):
-35.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-82.5%
Debt/Equity:
0.03
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.65 | $-0.57 | -14.0% | — | $850000 | — |
| 2025-08-06 | $-0.50 | $-0.52 | +3.8% | $4.0M | $833333 | +381.8% |
| 2025-05-12 | $-0.52 | $-0.66 | +21.2% | $2.9M | $457140 | +540.1% |
| 2025-03-19 | $-0.84 | $-0.68 | -23.5% | $2.7M | $3.1M | -13.0% |
| 2024-11-13 | $-0.78 | $-0.60 | -30.0% | $2.9M | $3.2M | -7.8% |
| 2024-08-12 | $-0.49 | $-0.38 | -28.9% | $2.4M | $2.5M | -7.3% |
| 2024-05-14 | $-0.34 | $-0.80 | +57.5% | $1.0M | $2.8M | -63.3% |
| 2024-03-28 | $-0.54 | $-0.28 | -92.9% | $3.8M | $2.1M | +85.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 9.04M | 14.02M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (292.96M) | (106.81M) | (36.90M) | (24.71M) | (17.84M) | (10.55M) | (7.84M) |
| EPS | -5.00 | -5.38 | -3.09 | -2.14 | -1.69 | -1.84 | -7.18 |
| Total Assets | 240.24M | 148.54M | 24.05M | 57.92M | 44.52M | 5.06M | 4.45M |
| Total Debt | 4.83M | 1.65M | 291,000 | 317,000 | 613,000 | 564,000 | 1.18M |
| Cash & Equivalents | 143.35M | 98.68M | 20.32M | 49.23M | 39.77M | 2.54M | 1.60M |
| Operating Cash Flow | (110.79M) | (7.57M) | (28.69M) | (18.23M) | (12.13M) | (9.60M) | (7.41M) |
| Free Cash Flow | (164.30M) | (8.40M) | (28.94M) | (18.30M) | (12.72M) | (9.83M) | (7.63M) |
| FCF per Share | -2.80 | -0.42 | -2.39 | -1.59 | -1.26 | -1.71 | -6.99 |
| Book Value | 181.16M | 119.88M | 16.65M | 48.19M | 41.34M | (35.63M) | (25.20M) |
| Cash & ST Investments | 217.30M | 138.14M | 20.32M | 49.23M | 39.77M | 2.54M | 1.60M |
| ROC Equity | -1.62 | -0.89 | -2.22 | -0.51 | -0.43 | N/A | N/A |